The value of pimecrolimus in improving quality of life of children with severe eczema — an open non-randomised study
Background: Atopic eczema is a common skin condition. It has the potential to severely impair quality of life in affected children. Pimecrolimus is currently registered for mild-moderate eczema but in clinical practice children with more severe disease are often treated with this therapy in an attem...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AOSIS
2010-02-01
|
| Edice: | South African Family Practice |
| Témata: | |
| On-line přístup: | https://safpj.co.za/index.php/safpj/article/view/1356 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|